 Valproate metabolism hepatotoxicity drug Plasma concentrations valproate certain metabolites patterns excretion urine adults hepatotoxicity treatment epilepsy sodium valproate patient degree reversible renal insufficiency infectious mononucleosis cases evidence impaired mitochondrial beta-oxidation valproate impairment stage fatty acyl-CoA dehydrogenase stage dehydrogenase third stage enoyl-CoA hydratase next stage dehydrogenase impaired beta-oxidation meant metabolism various alternative pathways Plasma concentrations suspected hepatotoxic metabolite normal valproate-treated population cases analogy certain spontaneous human disorders chain amino acid metabolism valproate-associated hepatotoxicity consequences valproate overload limited mitochondrial beta-oxidation capacity accumulation toxic product endogenous chain amino acid metabolism